14/06/2026
https://www.facebook.com/share/1bGa4WruwY/?mibextid=wwXIfr
A landmark study of over 1 million women reveals that endometriosis is a systemic whole-body condition linked to inflammation, cholesterol, and the microbiome.
For generations, endometriosis has been treated as an isolated pelvic issue, leaving millions of women struggling with chronic pain without systemic answers. Now, a groundbreaking multi-ancestry study of more than one million women has completely rewritten our understanding of the disease. Researchers identified over 300 genes associated with endometriosis, exposing deep-seated genetic connections to systemic inflammation, altered microbiomes, and lipid metabolism. Crucially, the study also uncovered genetic risk factors unique to women of African ancestry, offering a vital step forward in addressing historic diagnostic disparities and proving that the condition reaches far beyond the pelvis.
These discoveries open the door to radically new treatment methods that target the body's inflammatory and cellular pathways rather than relying solely on hormonal suppression or invasive surgeries. By shifting the clinical perspective from a purely gynecological focus to a systemic approach, doctors can begin designing personalized therapies that address the root metabolic and immune triggers. For patients who historically endure years of debilitating symptoms before receiving a diagnosis, this genetic blueprint offers a roadmap to faster, non-invasive screening and therapeutic hope.
source: Guare, L. A., Das, J., Caruth, L., Rajagopalan, A., Akerele, A. T., Brumpton, B. M., ... & Setia-Verma, S. (2025). Expanding the genetic landscape of endometriosis: Integrative -omics analyses implicate key genes and pathways in a multi-ancestry study of over one million women. medRxiv.
